• Search
  • Advanced Search
Diabetes Metab J > Volume 32(6); 2008 > Article
Letter
Korean Diabetes Journal 2008;32(6):532-533.
DOI: https://doi.org/10.4093/kdj.2008.32.6.532    Published online December 1, 2008.
The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.
Dong Lim Kim
Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University School of Medicine, Korea.
Abstract
No abstract available.
TOOLS
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 699 View
  • 0 Download
Related articles

Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus

Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus2021 July;45(4)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus2021 May;45(3)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus2021 May;45(3)

ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2022 by Korean Diabetes Association.

Developed in M2PI

Close layer